Arbutus Biopharma Corp. (ABUS)
4.72
+0.04
(+0.85%)
USD |
NASDAQ |
Apr 17, 16:00
4.715
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma SG&A Expense (Quarterly) : 3.689M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Moderna, Inc. | 308.00M |
| Merck & Co., Inc. | 2.898B |
| Pfizer Inc. | 4.162B |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |